The R. gnavus mucin-utilization enzymatic profile, which is mainly based on the release and use of sialic acid to support growth21, appears particularly well adapted to digest mucin with short chains terminated by sialic acid, such as sialyl-Tn-antigen, which is found in higher proportion in IBD patients49. The gene discussed is MUC5AC; the disease is inflammatory bowel disease.